Literature DB >> 20599761

Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster.

Mohd Akif1, Ioanna Ntai, Edward D Sturrock, R Elwyn Isaac, Brian O Bachmann, K Ravi Acharya.   

Abstract

Angiotensin-I converting enzyme (ACE, a zinc dependent dipeptidyl carboxypeptidase) is a major target of drugs due to its role in the modulation of blood pressure and cardiovascular disorders. Here we present a crystal structure of AnCE (an ACE homologue from Drosophila melanogaster with a single enzymatic domain) in complex with a natural product-phosphonotripeptide, K-26 at 1.96A resolution. The inhibitor binds exclusively in the S(1) and S(2) binding pockets of AnCE (coordinating the zinc ion) through ionic and hydrogen bond interactions. A detailed structural comparison of AnCE.K-26 complex with individual domains of human somatic ACE provides useful information for further exploration of ACE inhibitor pharmacophores involving phosphonic acids. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599761     DOI: 10.1016/j.bbrc.2010.06.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.

Authors:  Takako Nagai; Kyoko Nitta; Megumi Kanasaki; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2014-07-01       Impact factor: 2.801

Review 2.  Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE).

Authors:  Kenneth E Bernstein; Xiao Z Shen; Romer A Gonzalez-Villalobos; Sandrine Billet; Derick Okwan-Duodu; Frank S Ong; Sebastien Fuchs
Journal:  Curr Opin Pharmacol       Date:  2010-12-02       Impact factor: 5.547

3.  The antibiotic dehydrophos is converted to a toxic pyruvate analog by peptide bond cleavage in Salmonella enterica.

Authors:  Benjamin T Circello; Charles G Miller; Jin-Hee Lee; Wilfred A van der Donk; William W Metcalf
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

4.  Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes.

Authors:  Glenna J Kramer; Akif Mohd; Sylva L U Schwager; Geoffrey Masuyer; K Ravi Acharya; Edward D Sturrock; Brian O Bachmann
Journal:  ACS Med Chem Lett       Date:  2014-02-04       Impact factor: 4.345

Review 5.  N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Authors:  Keizo Kanasaki; Takako Nagai; Kyoko Nitta; Munehiro Kitada; Daisuke Koya
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

6.  The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.

Authors:  Zatul-'Iffah Abu Hasan; Helen Williams; Nur M Ismail; Hidayatulfathi Othman; Gyles E Cozier; K Ravi Acharya; R Elwyn Isaac
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 7.  ACE and ACE2: insights from Drosophila and implications for COVID-19.

Authors:  Paul Herrera; Ruben J Cauchi
Journal:  Heliyon       Date:  2021-12-07

8.  A new high-resolution crystal structure of the Drosophila melanogaster angiotensin converting enzyme homologue, AnCE.

Authors:  Charlotte Harrison; K Ravi Acharya
Journal:  FEBS Open Bio       Date:  2015-08-11       Impact factor: 2.693

9.  Crystal structure of a peptidyl-dipeptidase K-26-DCP from Actinomycete in complex with its natural inhibitor.

Authors:  Geoffrey Masuyer; Gyles E Cozier; Glenna J Kramer; Brian O Bachmann; K Ravi Acharya
Journal:  FEBS J       Date:  2016-11-06       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.